The new buprenorphine formulation is used as a substitution treatment in adults and adolescents 15 years or older who agree to be treated for addiction.
The Committee for Medicinal Products for Human Use said its recommendation was intended to cover use in adults and adolescents 15 years of age or older who had agreed to be treated forA hybrid medicine is similar to an authorized medicine containing the same active substance but has certain differences, such as in strength, indication, or pharmaceutical form.
Buprenorphine Neuraxpharm is a hybrid medicine of Subutex, a formulation of buprenorphine hydrochloride manufactured by Indivior UK Limited and available as 0.4 mg, 2 mg, and 8 mg sublingual tablets or as a prolonged-release solution for injection. Subutex has been authorized in the European Union since 1995.
Neuraxpharm Pharmaceuticals S.L. submitted a hybrid application for the sublingual film product, relying in part on the results of preclinical tests and clinical trials of the already authorized reference product, and in part on new data. The CHMP said that buprenorphine is a partial opioid agonist/antagonist and can be used as a substitute for opioids during addiction treatment. Buprenorphine Neuraxpharm is subject to special and restricted medical prescription. Treatment should be prescribed and supervised by a doctor experienced in the management of opiate dependence/addiction.
Buprenorphine Neuraxpharm will be available as 0.4 mg, 4 mg, 6 mg, and 8 mg sublingual films. Full recommendations will be described in the summary of product characteristics, which will be published after marketing authorization has been granted by the European Commission.
Addiction Drug/Treatment Safety Drug Safety Treatment Safety Drug Development Drug Discovery Drug Pipeline Drug Development Pipeline Drug Legislation Drug Registries Drug Registry Drug Regulation Adolescent Medicine Teens Teenage Teenager Adolescent Health Adolescents Adolescent Europe European Adverse Effects Side Effects Grant Abdominal Pain Patient Safety
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coastal Commission OKs revetment at San Elijo State BeachRecreational campsites being lost coastal erosion; site will be monitored for 5 years
Read more »
Hill Country city OKs millions to make historic home a museumKerrville estimates it will cost $6.7 million — about $5 million of that coming from public money — to bring new life to the A.C. Schreiner House.
Read more »
Port Authority OKs $15M in bonds for historic Taylor Tudor project in Cleveland HeightsWork on the project is expected to start by the end of this year, with completion planned by the second quarter of 2026.
Read more »
FDA OKs Next-Gen Cologuard Test for CRC ScreeningIn average-risk adults, Cologuard Plus demonstrated sensitivities of 95% for CRC and 43% for advanced precancerous lesions at 94% specificity in the pivotal BLUE-C trial.
Read more »
Cleveland Planning Commission OKs architectural plans for Cleveland Clinic, Cavs facility along riverfrontBedrock on Friday received approval from the Cleveland City Planning Commission for its architectural plans for the Cleveland Clinic Global Peak Performance Center
Read more »
FTX Customers Will Get Back Billions After Judge OKs Bankruptcy PlanA US judge has authorized a plan for fallen crypto exchange FTX to return money to former customers, as the drawn-out bankruptcy process approaches its end.
Read more »